In breast cancer, CAF-derived Gal1 helps to delimitate the immunosuppressive microenvironment by shifting it to a Th2 cytokine profile and increasing the frequency of Treg cells [168, 169]. The gene discussed is LGALS1; the disease is breast cancer.